Detalhe da pesquisa
1.
Site-specific PEGylation of human thyroid stimulating hormone to prolong duration of action.
Bioconjug Chem;
24(3): 408-18, 2013 Mar 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23350694
2.
Site-Specific Antibody Conjugation to Engineered Double Cysteine Residues.
Pharmaceuticals (Basel);
14(7)2021 Jul 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34358098
3.
Engineered Fc-glycosylation switch to eliminate antibody effector function.
MAbs;
12(1): 1814583, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32892677
4.
Structure-based engineering to restore high affinity binding of an isoform-selective anti-TGFß1 antibody.
MAbs;
10(3): 444-452, 2018 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29333938
5.
Impact of cysteine variants on the structure, activity, and stability of recombinant human α-galactosidase A.
Protein Sci;
24(9): 1401-11, 2015 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26044846
6.
Carbohydrate-mediated polyethylene glycol conjugation of TSH improves its pharmacological properties.
Endocrinology;
154(3): 1373-83, 2013 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23389953
7.
In vitro and in vivo evaluation of a non-carbohydrate targeting platform for lysosomal proteins.
J Control Release;
135(2): 113-8, 2009 Apr 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19146893